Fig. 2From: Metformin exhibits the anti-proliferation and anti-invasion effects in hepatocellular carcinoma cells after insufficient radiofrequency ablationMetformin may regulate HCC cells proliferation, migration and invasion after insufficient RFA by promoting AMPK/PTEN/Akt pathway. Metformin was used to treat HepG2 cells, and western blot was used to determined the expression of p-AMPK, PTEN, p-Akt, E-cadherin, PCNA and VEGFBack to article page